.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Chubb
US Department of Justice
Moodys
Medtronic
Daiichi Sankyo
Novartis
Argus Health
Healthtrust

Generated: December 15, 2017

DrugPatentWatch Database Preview

A-N STANNOUS AGGREGATED ALBUMIN Drug Profile

« Back to Dashboard

When do A-n Stannous Aggregated Albumin patents expire, and when can generic versions of A-n Stannous Aggregated Albumin launch?

A-n Stannous Aggregated Albumin is a drug marketed by Syncor Pharms and is included in one NDA.

The generic ingredient in A-N STANNOUS AGGREGATED ALBUMIN is technetium tc-99m albumin aggregated kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m albumin aggregated kit profile page.

Summary for A-N STANNOUS AGGREGATED ALBUMIN

Drug patent expirations by year for A-N STANNOUS AGGREGATED ALBUMIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Syncor PharmsA-N STANNOUS AGGREGATED ALBUMINtechnetium tc-99m albumin aggregated kitINJECTABLE;INJECTION017916-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
QuintilesIMS
US Department of Justice
US Army
UBS
McKesson
Cerilliant
AstraZeneca
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot